Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL’HIV open-label, factorial randomised controlled trial. (2024). Swiss Medical Weekly, 154(4), 3762. https://doi.org/10.57187/s.3762